Cargando…
Investigation of the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy for brainstem metastases using a new evaluation criterion: ‘symptomatic control’
The treatment of brainstem metastases remains a challenge as the brainstem itself is considered a neurological organ at risk. We aimed to investigate the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy (HFSRT) for brainstem metastases, and to examine the balance between...
Autores principales: | Nakamura, Masaki, Nishimura, Hideki, Mayahara, Hiroshi, Uezono, Haruka, Harada, Aya, Hashimoto, Naoki, Ejima, Yasuo, Ishihara, Takeaki, Nishikawa, Ryo, Sasaki, Ryohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710515/ https://www.ncbi.nlm.nih.gov/pubmed/28992239 http://dx.doi.org/10.1093/jrr/rrx042 |
Ejemplares similares
-
Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer
por: Nakamura, Masaki, et al.
Publicado: (2016) -
CyberKnife Stereotactic Radiosurgery for Cholangiocarcinoma
por: Harada, Yuko, et al.
Publicado: (2017) -
Promising Outcomes in Acromegaly Patients Receiving CyberKnife Stereotactic Hypofractionated Radiotherapy
por: Meral, Rasim, et al.
Publicado: (2023) -
CyberKnife Stereotactic Radiosurgery for Primary and Metastatic Cancer in the Cervix
por: Harada, Yuko, et al.
Publicado: (2017) -
Thymic Carcinoma Treated by CyberKnife Stereotactic Body Radiotherapy
por: Harada, Yuko, et al.
Publicado: (2017)